AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Entropy Neurodynamics Ltd

0.039

+0.0011.30%

Volume:484.11K

Turnover:18.60K

Market Cap:63.61M

PE:-12.56

High:0.040

Open:0.039

Low:0.038

Close:0.039

52wk High:0.043

52wk Low:0.025

Shares:1.63B

Float Shares:878.05M

Volume Ratio:0.35

T/O Rate:0.06%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.003

EPS(LYR):-0.003

ROE:-73.07%

ROA:-40.38%

PB:8.64

PE(LYR):-12.58

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Entropy Neurodynamics Says All Patients Show Improvement in Phase 2 Binge Eating Disorder Trial; Shares Up 3%

MT Newswires Live

Entropy Neurodynamics Ltd - FY Loss Attributable A$4.9 Mln

THOMSON REUTERS

Entropy Neurodynamics Ltd - no Dividends Paid, Recommended or Declared During the Current Financial Period

THOMSON REUTERS

Entropy Neurodynamics Seeks Trading Halt

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigeractivity.com/stock/ENP.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"ENP.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ENP.AU\",,,,,undefined,":{"symbol":"ENP.AU","market":"AU","secType":"STK","nameCN":"Entropy Neurodynamics Ltd","latestPrice":0.039,"timestamp":1790921520000,"preClose":0.0385,"halted":0,"volume":484107,"delay":0,"changeRate":0.012987012987012998,"nameEN":"Entropy Neurodynamics Ltd","floatShares":878046607,"shares":1631064683,"eps":-0.003104,"marketStatus":"Closed","change":0.0005,"latestTime":"10-02 16:12:00 AEST","open":0.039,"high":0.04,"low":0.038,"amount":18603,"amplitude":0.051948,"askPrice":0.039,"askSize":53132,"bidPrice":0.038,"bidSize":1175000,"shortable":3,"etf":0,"ttmEps":-0.003104,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1791154800000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":0.0385,"openAndCloseTimeList":[[1790899200000,1790920800000]],"volumeRatio":0.351661,"lotSize":0,"tradeCurrency":"AUD","auctionPricing":{"symbol":"ENP.AU","preClose":0.0385,"auctionPrice":0.039,"auctionVolume":13545,"auctionTime":1790921393850,"referencePrice":0.039,"referenceTime":1790923320429,"auction":3,"marketStatus":"盘后竞价","timestamp":1790921393850}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ENP.AU\",,,,,undefined,":{"symbol":"ENP.AU","floatShares":878046607,"roa":"-40.38%","roe":"-73.07%","lyrEps":-0.0031,"volumeRatio":0.351661,"shares":1631064683,"dividePrice":0,"high":0.04,"amplitude":0.051948,"preClose":0.0385,"low":0.038,"week52Low":0.025,"pbRate":"8.64","psRate":"33.37","week52High":0.043,"institutionHeld":0,"latestPrice":0.039,"committee":0.913475,"eps":-0.003104,"divideRate":0,"volume":484107,"delay":0,"ttmEps":-0.003104,"open":0.039,"prevYearClose":0.033,"prevWeekClose":0.041,"prevMonthClose":0.039,"prevQuarterClose":0.039,"fiveDayClose":0.041,"twentyDayClose":0.041,"sixtyDayClose":0.035},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ENP.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ENP.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ENP.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667663244","title":"Entropy Neurodynamics Says All Patients Show Improvement in Phase 2 Binge Eating Disorder Trial; Shares Up 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2667663244","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667663244?lang=en_us&edition=fundamental","pubTime":"2026-09-14 12:05","pubTimestamp":1789358736,"startTime":"0","endTime":"0","summary":"Entropy Neurodynamics  said all six treatment-resistant binge eating disorder patients in group 1 of its phase 2 trial of TRP-8803, an intravenously infused psilocin drug candidate, showed a \"clinically meaningful improvement\" in symptoms for the full 12-week follow-up period, according to a Monday Australian bourse filing.The company said 50% of patients experienced no binge-eating episodes during the entire 84-day follow-up period after completing two TRP-8803 infusions, with weekly binge-eating episodes 73% below pretreatment baseline at 12 weeks, substantially maintaining the 74% reduction observed at four weeks.For group 2, the company will evaluate a shorter TRP-8803 infusion period, with top-line results expected in the fourth quarter of the year, the filing added.The company's shares rose almost 3% in recent Monday trade.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ENP.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662710031","title":"Entropy Neurodynamics Ltd - FY Loss Attributable A$4.9 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2662710031","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662710031?lang=en_us&edition=fundamental","pubTime":"2026-08-28 07:46","pubTimestamp":1787874390,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nFWN44O1KB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","ENP.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662031741","title":"Entropy Neurodynamics Ltd - no Dividends Paid, Recommended or Declared During the Current Financial Period","url":"https://stock-news.laohu8.com/highlight/detail?id=2662031741","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662031741?lang=en_us&edition=fundamental","pubTime":"2026-08-28 07:46","pubTimestamp":1787874390,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nFWN44O1KB:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ENP.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661244254","title":"Entropy Neurodynamics Seeks Trading Halt","url":"https://stock-news.laohu8.com/highlight/detail?id=2661244254","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661244254?lang=en_us&edition=fundamental","pubTime":"2026-08-24 09:38","pubTimestamp":1787535481,"startTime":"0","endTime":"0","summary":"BRIEF-Entropy Neurodynamics Seeks Trading HaltAug 24 (Reuters)-Entropy Neurodynamics LtdENP.AX:TRADING HALT PENDING ANNOUNCEMENT ON US PHASE 2 CLINICAL TRIAL WITH PROF. ROBIN CARHART-HARRISFurther company coverage:ENP.AX","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nFWN44J097:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENP.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":8,"pageCount":1,"totalSize":29,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/ENP.AU\",params:#limit:6,delay:true,,,undefined,":[]}}